A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population

Tasuku Hashimoto, Kenji Hashimoto, Daisuke Matsuzawa, Eiji Shimizu, Yoshimoto Sekine, Toshiya Inada, Norio Ozaki, Nakao Iwata, Mutsuo Harano, Tokutaro Komiyama, Mitsuhiko Yamada, Ichiro Sora, Hiroshi Ujike, Masaomi Iyo

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Several lines of evidence suggest that oxidative stress plays a role in the mechanisms of action of methamphetamine (MAP) in the human brain. Given the role of glutathione S-transferases (GSTs) in the protection against oxidative stress, genes encoding the GSTs have been considered as candidates for association studies of MAP abuse. This study was undertaken to investigate the role of the functional polymorphism of GSTP1 gene exon 5 (Ile105Val) in the pathogenesis of MAP abuse. Genotyping for GSTP1 gene polymorphism exon 5 (Ile105Val) in 189 MAP abusers and 199 normal controls was performed by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP). Association between GSTP1 gene polymorphism and clinical features (prognosis of psychosis (transient-type and prolonged-type), spontaneous relapse (positive and negative), and poly-substance abuse) of MAP abusers was evaluated. Significant differences in the frequency of both alleles (P = 0.026, odds ratio: 1.70, 95% confidence intervals (CI) 1.06-2.72) and genotypes (P = 0.029) between MAP abusers and controls were detected. In particular, a significant difference in both genotype frequency (P = 0.013) and allele frequency (P = 0.014, odds ratio: 1.84, 95% CI 1.13-2.97) between MAP abusers with psychosis (transient-type and prolonged-type) and controls was detected. Our findings suggest that the polymorphism (Ile105Val) on exon 5 of the GSTP1 gene may contribute to a vulnerability to psychosis associated with MAP abuse in Japanese population.

Original languageEnglish
Pages (from-to)5-9
Number of pages5
JournalAmerican Journal of Medical Genetics - Neuropsychiatric Genetics
Volume135 B
Issue number1
DOIs
Publication statusPublished - 05-05-2005

Fingerprint

Methamphetamine
Glutathione Transferase
Psychotic Disorders
Population
Genes
Exons
Gene Frequency
Oxidative Stress
Odds Ratio
Genotype
Confidence Intervals
Restriction Fragment Length Polymorphisms
Substance-Related Disorders
Recurrence
Polymerase Chain Reaction
Brain

All Science Journal Classification (ASJC) codes

  • Genetics(clinical)
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

Hashimoto, Tasuku ; Hashimoto, Kenji ; Matsuzawa, Daisuke ; Shimizu, Eiji ; Sekine, Yoshimoto ; Inada, Toshiya ; Ozaki, Norio ; Iwata, Nakao ; Harano, Mutsuo ; Komiyama, Tokutaro ; Yamada, Mitsuhiko ; Sora, Ichiro ; Ujike, Hiroshi ; Iyo, Masaomi. / A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population. In: American Journal of Medical Genetics - Neuropsychiatric Genetics. 2005 ; Vol. 135 B, No. 1. pp. 5-9.
@article{2c34daad2a4342f0ba2743bcbc655274,
title = "A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population",
abstract = "Several lines of evidence suggest that oxidative stress plays a role in the mechanisms of action of methamphetamine (MAP) in the human brain. Given the role of glutathione S-transferases (GSTs) in the protection against oxidative stress, genes encoding the GSTs have been considered as candidates for association studies of MAP abuse. This study was undertaken to investigate the role of the functional polymorphism of GSTP1 gene exon 5 (Ile105Val) in the pathogenesis of MAP abuse. Genotyping for GSTP1 gene polymorphism exon 5 (Ile105Val) in 189 MAP abusers and 199 normal controls was performed by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP). Association between GSTP1 gene polymorphism and clinical features (prognosis of psychosis (transient-type and prolonged-type), spontaneous relapse (positive and negative), and poly-substance abuse) of MAP abusers was evaluated. Significant differences in the frequency of both alleles (P = 0.026, odds ratio: 1.70, 95{\%} confidence intervals (CI) 1.06-2.72) and genotypes (P = 0.029) between MAP abusers and controls were detected. In particular, a significant difference in both genotype frequency (P = 0.013) and allele frequency (P = 0.014, odds ratio: 1.84, 95{\%} CI 1.13-2.97) between MAP abusers with psychosis (transient-type and prolonged-type) and controls was detected. Our findings suggest that the polymorphism (Ile105Val) on exon 5 of the GSTP1 gene may contribute to a vulnerability to psychosis associated with MAP abuse in Japanese population.",
author = "Tasuku Hashimoto and Kenji Hashimoto and Daisuke Matsuzawa and Eiji Shimizu and Yoshimoto Sekine and Toshiya Inada and Norio Ozaki and Nakao Iwata and Mutsuo Harano and Tokutaro Komiyama and Mitsuhiko Yamada and Ichiro Sora and Hiroshi Ujike and Masaomi Iyo",
year = "2005",
month = "5",
day = "5",
doi = "10.1002/ajmg.b.30164",
language = "English",
volume = "135 B",
pages = "5--9",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley-Liss Inc.",
number = "1",

}

Hashimoto, T, Hashimoto, K, Matsuzawa, D, Shimizu, E, Sekine, Y, Inada, T, Ozaki, N, Iwata, N, Harano, M, Komiyama, T, Yamada, M, Sora, I, Ujike, H & Iyo, M 2005, 'A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population', American Journal of Medical Genetics - Neuropsychiatric Genetics, vol. 135 B, no. 1, pp. 5-9. https://doi.org/10.1002/ajmg.b.30164

A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population. / Hashimoto, Tasuku; Hashimoto, Kenji; Matsuzawa, Daisuke; Shimizu, Eiji; Sekine, Yoshimoto; Inada, Toshiya; Ozaki, Norio; Iwata, Nakao; Harano, Mutsuo; Komiyama, Tokutaro; Yamada, Mitsuhiko; Sora, Ichiro; Ujike, Hiroshi; Iyo, Masaomi.

In: American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 135 B, No. 1, 05.05.2005, p. 5-9.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population

AU - Hashimoto, Tasuku

AU - Hashimoto, Kenji

AU - Matsuzawa, Daisuke

AU - Shimizu, Eiji

AU - Sekine, Yoshimoto

AU - Inada, Toshiya

AU - Ozaki, Norio

AU - Iwata, Nakao

AU - Harano, Mutsuo

AU - Komiyama, Tokutaro

AU - Yamada, Mitsuhiko

AU - Sora, Ichiro

AU - Ujike, Hiroshi

AU - Iyo, Masaomi

PY - 2005/5/5

Y1 - 2005/5/5

N2 - Several lines of evidence suggest that oxidative stress plays a role in the mechanisms of action of methamphetamine (MAP) in the human brain. Given the role of glutathione S-transferases (GSTs) in the protection against oxidative stress, genes encoding the GSTs have been considered as candidates for association studies of MAP abuse. This study was undertaken to investigate the role of the functional polymorphism of GSTP1 gene exon 5 (Ile105Val) in the pathogenesis of MAP abuse. Genotyping for GSTP1 gene polymorphism exon 5 (Ile105Val) in 189 MAP abusers and 199 normal controls was performed by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP). Association between GSTP1 gene polymorphism and clinical features (prognosis of psychosis (transient-type and prolonged-type), spontaneous relapse (positive and negative), and poly-substance abuse) of MAP abusers was evaluated. Significant differences in the frequency of both alleles (P = 0.026, odds ratio: 1.70, 95% confidence intervals (CI) 1.06-2.72) and genotypes (P = 0.029) between MAP abusers and controls were detected. In particular, a significant difference in both genotype frequency (P = 0.013) and allele frequency (P = 0.014, odds ratio: 1.84, 95% CI 1.13-2.97) between MAP abusers with psychosis (transient-type and prolonged-type) and controls was detected. Our findings suggest that the polymorphism (Ile105Val) on exon 5 of the GSTP1 gene may contribute to a vulnerability to psychosis associated with MAP abuse in Japanese population.

AB - Several lines of evidence suggest that oxidative stress plays a role in the mechanisms of action of methamphetamine (MAP) in the human brain. Given the role of glutathione S-transferases (GSTs) in the protection against oxidative stress, genes encoding the GSTs have been considered as candidates for association studies of MAP abuse. This study was undertaken to investigate the role of the functional polymorphism of GSTP1 gene exon 5 (Ile105Val) in the pathogenesis of MAP abuse. Genotyping for GSTP1 gene polymorphism exon 5 (Ile105Val) in 189 MAP abusers and 199 normal controls was performed by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP). Association between GSTP1 gene polymorphism and clinical features (prognosis of psychosis (transient-type and prolonged-type), spontaneous relapse (positive and negative), and poly-substance abuse) of MAP abusers was evaluated. Significant differences in the frequency of both alleles (P = 0.026, odds ratio: 1.70, 95% confidence intervals (CI) 1.06-2.72) and genotypes (P = 0.029) between MAP abusers and controls were detected. In particular, a significant difference in both genotype frequency (P = 0.013) and allele frequency (P = 0.014, odds ratio: 1.84, 95% CI 1.13-2.97) between MAP abusers with psychosis (transient-type and prolonged-type) and controls was detected. Our findings suggest that the polymorphism (Ile105Val) on exon 5 of the GSTP1 gene may contribute to a vulnerability to psychosis associated with MAP abuse in Japanese population.

UR - http://www.scopus.com/inward/record.url?scp=20244383743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20244383743&partnerID=8YFLogxK

U2 - 10.1002/ajmg.b.30164

DO - 10.1002/ajmg.b.30164

M3 - Article

C2 - 15729709

AN - SCOPUS:20244383743

VL - 135 B

SP - 5

EP - 9

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 1

ER -